|Articles|August 23, 2022

Worldwide Clinical Trials Expands With New Lab at Bioanalytical Center of Excellence

CRO expands its Early Phase large molecule capabilities and services with a new 15,000 square foot dedicated lab.

Worldwide Clinical Trials, Inc. has expanded its Early Phase large molecule capabilities and services with a new 15,000 square foot dedicated lab at its Bioanalytical Center of Excellence in Austin, TX.

The added capacity enables Worldwide to provide its sponsors with optimized sample processing and analysis workflows for minimal turnaround times.

Read more about the new facility here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content